We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

48 hedge funds and large institutions have $13.8M invested in vTv Therapeutics in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more capital invested

Capital invested by funds: $4.94M → $13.8M (+$8.87M)

144% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 9

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

9% more funds holding

Funds holding: 44 → 48 (+4)

0.08% more ownership

Funds ownership: 0.12% → 0.21% (+0.08%)

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$1.73M
2
Two Sigma Investments
Two Sigma Investments
New York
+$927K
3
Citadel Advisors
Citadel Advisors
Florida
+$442K
4
Marshall Wace
Marshall Wace
United Kingdom
+$435K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$372K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$140K
2
VF
Virtu Financial
New York
-$70K
3
Squarepoint
Squarepoint
New York
-$61K
4
N
Natixis
France
-$42K
5
OQS
Occudo Quantitative Strategies
Florida
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.28M +$222K +2,255 +13%
N
2
Nuveen
North Carolina
$2.1M +$1.73M +17,586 +1,699%
BlackRock
3
BlackRock
New York
$1.34M +$88.4K +900 +8%
Two Sigma Investments
4
Two Sigma Investments
New York
$1.06M +$927K +9,437 New
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$909K +$330K +3,354 +71%
State Street
6
State Street
Massachusetts
$786K +$251K +2,551 +58%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$754K +$239K +2,431 +57%
Two Sigma Advisers
8
Two Sigma Advisers
New York
$560K +$372K +3,790 +323%
Citadel Advisors
9
Citadel Advisors
Florida
$508K +$442K +4,502 New
Marshall Wace
10
Marshall Wace
United Kingdom
$499K +$435K +4,425 New
Northern Trust
11
Northern Trust
Illinois
$460K +$55.6K +566 +16%
WAG
12
Winthrop Advisory Group
Massachusetts
$347K +$295 +3 +5%
CIM
13
CIM Investment Management
Pennsylvania
$344K +$299K +3,045 New
Vontobel Holding
14
Vontobel Holding
Switzerland
$226K +$86K +875 +78%
CFG
15
Citizens Financial Group
Rhode Island
$197K +$172K +1,750 New
Goldman Sachs
16
Goldman Sachs
New York
$178K +$155K +1,574 New
Cetera Investment Advisers
17
Cetera Investment Advisers
Illinois
$134K +$117K +1,186 New
SFI
18
Susquehanna Fundamental Investments
Pennsylvania
$100K +$9.63K +98 +12%
EGM
19
Engineers Gate Manager
New York
$95K -$2.65K -27 -3%
New York State Common Retirement Fund
20
New York State Common Retirement Fund
New York
$91K -$22.8K -232 -22%
JP Morgan Chase
21
JP Morgan Chase
New York
$90K +$14K +142 +22%
AQR Capital Management
22
AQR Capital Management
Connecticut
$88K +$76.6K +780 New
Invesco
23
Invesco
Georgia
$85K +$982 +10 +1%
PPA
24
Parametric Portfolio Associates
Washington
$74K +$18.6K +189 +41%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$64K -$1.47K -15 -3%
1
2 3

VTVT Hedge Fund Activity: Q1 2021 in Review

48 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q1 2021, worth a combined $13.8M — up 180% from $4.94M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VTVT positions and 7 closed out — a net gain of 5 holders — while 22 added to existing stakes and 9 trimmed.

The largest buyer was Nuveen, adding an estimated $1.73M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $140K sold.

  • 48 institutional investors held vTv Therapeutics (VTVT) as of Q1 2021, up from 44 in Q4 2020.
  • Funds reported $13.8M of vTv Therapeutics stock for Q1 2021, up 180% quarter-over-quarter.
  • 12 funds opened new vTv Therapeutics positions in Q1 2021 and 7 closed out, a net change of +5 holders.
  • The largest vTv Therapeutics buyer in Q1 2021 was Nuveen, an estimated $1.73M added.
  • The largest vTv Therapeutics seller in Q1 2021 was Renaissance Technologies, an estimated $140K sold.

Based on aggregated 13F filings for Q1 2021.